Holen Sie sich die Stockscreener-App
2.75
4.17%
0.11
Handel nachbörslich:
2.75
Schlusskurs vom Vortag:
$2.64
Offen:
$2.66
24-Stunden-Volumen:
326.97K
Relative Volume:
0.59
Marktkapitalisierung:
$256.64M
Einnahmen:
$25.14M
Nettoeinkommen (Verlust:
$-21.57M
KGV:
-10.19
EPS:
-0.27
Netto-Cashflow:
$-12.23M
1W Leistung:
+0.00%
1M Leistung:
+17.52%
6M Leistung:
+23.32%
1J Leistung:
+26.73%
1-Tages-Spanne:
$2.64
$2.76
1-Wochen-Bereich:
$2.59
$2.86
52-Wochen-Spanne:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Vergleichen Sie STXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.75 | 246.38M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
523.69 | 186.98B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
206.18 | 57.95B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.62 | 38.83B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.28 | 36.96B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.30 | 36.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Should value investors consider Stereotaxis IncEarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Why Stereotaxis Inc. stock is popular among millennialsEarnings Trend Report & Verified Entry Point Detection - bollywoodhelpline.com
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles? - Nasdaq
Insider Sell: Is Stereotaxis Inc stock resilient to inflationQuarterly Risk Review & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Robotics in EP and Cath Labs - Diagnostic and Interventional Cardiology
What sentiment indicators say about Stereotaxis Inc. stockPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Is Stereotaxis Inc. stock cheap by valuation metricsJuly 2025 Institutional & Technical Buy Zone Confirmations - Улправда
Is Stereotaxis Inc. stock positioned for digital transformationJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - Улправда
St. Louis-based Stereotaxis gets FDA nod for robotic heart device central to growth strategy - The Business Journals
How Stereotaxis Inc. stock performs during Fed tightening cyclesEarnings Per Share Trends & Big Returns, Small Investment – Learn How - Улправда
Analysts Offer Insights on Healthcare Companies: Candel Therapeutics (CADL) and Stereotaxis (STXS) - The Globe and Mail
Stereotaxis wins FDA approval for robotically navigated ablation catheter - MedTech Dive
Stereotaxis (NYSEAMERICAN:STXS) Trading 8.1% HigherWhat's Next? - MarketBeat
Stereotaxis’ Magic magnetic ablation gets FDA nod - BioWorld MedTech
Stereotaxis stock soars after FDA approval of robotic ablation catheter By Investing.com - Investing.com Canada
Stereotaxis Wins Approval for MAGic Catheter - Medical Device and Diagnostic industry
Stereotaxis Shares Advance on FDA Approval for Magnetic Catheter - marketscreener.com
Stereotaxis Wins FDA Nod for MAGiC Magnetic Ablation Catheter - Medical Product Outsourcing
Stereotaxis Says US FDA Approves MAGiC Magnetic Interventional Ablation Catheter - marketscreener.com
Stereotaxis receives FDA approval for Magic ablation catheter - marketscreener.com
Stereotaxis (STXS) Gains FDA Approval for MAGiC Ablation Catheter - GuruFocus
Stereotaxis Says FDA Approves MAGiC Magnetic Interventional Ablation Catheter - Nasdaq
Stereotaxis gets FDA approval for magnetic ablation catheter By Investing.com - Investing.com India
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter - GlobeNewswire
STXSStereotaxis Reports 2019 Third Quarter Financial Results - ADVFN
Signal Recap: Can Stereotaxis Inc stock sustain free cash flow growthJuly 2025 Drop Watch & Consistent Profit Trading Strategies - Bộ Nội Vụ
Robotic Catheterization Systems Market | Global Market Analysis Report2036 - Future Market Insights
The Blend of CEO & Investor Synergy in Stereotaxis - Medical Device and Diagnostic industry
How Stereotaxis Inc. stock compares with top peersJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Улправда
Stereotaxis shares drop after Q3 loss widens, GenesisX limited launch underway - MSN
Will Stereotaxis Inc. stock deliver long term returns2025 Technical Patterns & Momentum Based Trading Ideas - DonanımHaber
How Stereotaxis Inc. stock valuation compares with sector2025 Risk Factors & Daily Volume Surge Signals - Улправда
CEO Moves: Why Stereotaxis Inc. stock is popular among millennialsJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - moha.gov.vn
Stereotaxis (NYSEAMERICAN:STXS) Now Covered by Citizens Jmp - Defense World
Citizens Jmp Begins Coverage on Stereotaxis (NYSEAMERICAN:STXS) - MarketBeat
This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Sahm
Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - Nasdaq
Stereotaxis (STXS): Analyst Initiates Coverage with "Market Outp - GuruFocus
Citizens initiates Stereotaxis stock with Market Outperform rating on robotic surgery growth - Investing.com India
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.1%Here's Why - MarketBeat
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.1% – Here’s Why - Defense World
3 Underrated Robotics Stocks Poised for Huge Gains - Finviz
Short Squeeze: Why Stereotaxis Inc stock is a strong analyst pickJuly 2025 Retail & AI Enhanced Execution Alerts - moha.gov.vn
Why Stereotaxis Inc. stock could be top winner2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Is Stereotaxis Inc. stock vulnerable to rate hikesWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-12-05 00:51:23 - Newser
Published on: 2025-12-04 13:10:01 - Newser
Stereotaxis Inc (STXS) is looking forward to a strong quarter - Setenews
Why analysts maintain buy rating on Stereotaxis Inc. stock2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Can Stereotaxis Inc. stock hold up in economic slowdownOptions Play & Long-Term Investment Growth Plans - Newser
Stereotaxis, Inc. (STXS) -5.5% in After-hours: Trading Amid Routine Activity - Stocks Telegraph
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):